Please login to the form below

Not currently logged in

Rise of generics will curb France’s pharma growth

Generics are set to take a serious bite out of the market as a cash-strapped government pushes for cost controls

Curbing the rise of drug resistance

The pharma sector could hold the greatest power to address the global threat of antimicrobial resistance

Choices, choices: the rapidly evolving HIV treatment landscape

Doctor writing prescription for medicinesThe treatment options for HIV in Europe has seen some revolutionary changes

Russian innovation at the crossroads

Despite improvements, investors face rising risks

Deal Watch table for January 2015

Deal Watch tableTable listing all the major pharma mergers, acquisitions and collaborations in the past month


Next-generation KOL intelligence

Advances in KOL intelligence are delivering richer insights into clinical landscapes than ever before, better enabling pharma to meet the challenges of an increasingly competitive and complex environment for KOL

Is co-creation the key to customer-centricity?

As pharma grapples with the need to becomemore doctor- and patient-centric, can co-creation help it better engage andconnect with its audience by redefining industry relationships with physicians and improve patient

Holistic market access and the importance of early engagement

Holistic market accessThere are two key elements in any successful strategy: knowing what to do, and knowing when to do it. Yet in terms of market access, there appears to be a

Digital: Fallacy or the Future Face of Pharma Marketing?

Digital: Fallacy or the Future Face of Pharma MarketingReach is one thing, trust is another. Digital channels may well be are growing in reach, but recent research from Cello Health Insight found that when it comes to trust,

Country reports

Is obesity really a problem in Brazil?

Obesity is on the rise in low- and middle-income countries, particularly in urban settings

Turkey: A growing pharma market with huge potential

The Turkish biopharma market offers many opportunities - if it can overcome its sustainability challenge

Creating a 21st century life sciences ecosystem

UK life sciences minister George FreemanThe UK’s life sciences minister on how government and pharma can encourage NHS uptake and innovation


The challenge of antimicrobial resistance

Cubist Patrick-Vink Cubist's Patrick Vink on the company's ambitions in anti-infectives

Switching to a virtual healthcare system

babylon virtual health service Ali Parsa, CEO and founder of babylon, discusses the benefits of conducting healthcare consultations via a smartphone

The role of artificial intelligence in healthcare

Watson on jeopardy IBM's Amer Fasihi on the rise of Watson

White papers

Healthy narratives?

In medical market research we see that most physicians are not early adopters, preferring to wait for their colleagues to adopt new medicines and practices before doing so themselves. There

Allergies – Always a story

Saycomms looks into the seasonal trend of allergies stories in the media and the communication campaigns launched in UK in 2015.

When is sun safety doing more harm than good?

Say Communications analyses the impact of sun safety campaigns in the news and on consumers

Energy drinks and heart disease

Say Communications analyses the link between energy drinks and heart disease and how the issue has been covered in the media.

Featured jobs

Subscribe to our email news alerts


Add my company

We are COUCH, a digital and creative healthcare communications agency based in Manchester with a focus on improving the customer...